Press Releases

05.11.2015
Ophthotech Reports First Quarter 2015 Financial and Operating Results
05.11.2015
Ophthotech Completes Patient Recruitment of the First Phase 3 Pivotal Trial of Fovista® Anti-PDGF Therapy in Combination with Lucentis® in Wet Age-Related Macular Degeneration Program
05.06.2015
Ophthotech Corporation to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
05.05.2015
Ophthotech Corporation to Announce First Quarter 2015 Financial Results and Host Conference Call on Monday, May 11, 2015
05.04.2015
Ophthotech Corporation to Present at the Deutsche Bank 40th Annual Health Care Conference
03.10.2015
Ophthotech Corporation Achieves Second $50 Million Enrollment Milestone under Ex-US Licensing and Commercial Agreement with Novartis for Fovista®
03.03.2015
Ophthotech Corporation to Present at the Barclays Global Healthcare Conference
02.23.2015
Ophthotech Reports Fourth Quarter and Full Year 2014 Financial and Operating Results
02.18.2015
Ophthotech Corporation to Announce Fourth Quarter and Full Year 2014 Financial Results and Host Conference Call on Monday, February 23, 2015
02.05.2015
Ophthotech Corporation to Present at the Leerink Global Healthcare Conference